We are live on
!
Find out more
BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
15 hedge funds and large institutions have $1.04M invested in Better Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
12% less funds holding
Funds holding: 17 → 15 (-2)
40% less capital invested
Capital invested by funds: $1.75M → $1.04M (-$704K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
5
Reduced
3
Closed
2
Calls
$84K
Puts
–
Net Calls
+$84K
Net Calls Change
-$85K
Top Buyers
| 1 |
Millennium Management
New York
|
+$17.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.35K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.1K |
| 5 |
BlackRock
New York
|
+$937 |
